News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vectura Limited Revenue Up, Key Drugs to Start Phase III


5/19/2009 7:26:39 AM

Bookmark and Share

Reuters -- British inhaled drug specialist Vectura reported a bigger-than-expected rise in full-year revenue and a smaller loss, and said on Tuesday two key new drugs were set to enter final-stage clinical tests.


Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES